ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $2,739,000 | +9.8% | 1,876,137 | +6.8% | 0.00% | 0.0% |
Q4 2016 | $2,494,000 | -16.8% | 1,756,801 | +2.6% | 0.00% | -50.0% |
Q3 2016 | $2,996,000 | +3.4% | 1,712,260 | +1.0% | 0.00% | 0.0% |
Q2 2016 | $2,898,000 | -12.0% | 1,695,179 | +1.3% | 0.00% | 0.0% |
Q1 2016 | $3,295,000 | +12.0% | 1,672,885 | +8.0% | 0.00% | 0.0% |
Q4 2015 | $2,942,000 | +1.3% | 1,549,235 | +1.9% | 0.00% | 0.0% |
Q3 2015 | $2,903,000 | -58.8% | 1,520,222 | +0.2% | 0.00% | -50.0% |
Q2 2015 | $7,038,000 | +8.2% | 1,516,926 | +1.9% | 0.00% | 0.0% |
Q1 2015 | $6,505,000 | +45.4% | 1,488,601 | +15.5% | 0.00% | +33.3% |
Q4 2014 | $4,473,000 | -14.8% | 1,289,246 | +2.9% | 0.00% | 0.0% |
Q3 2014 | $5,250,000 | -29.0% | 1,253,163 | -0.8% | 0.00% | -40.0% |
Q2 2014 | $7,399,000 | -3.8% | 1,262,732 | +3.5% | 0.01% | 0.0% |
Q1 2014 | $7,688,000 | +22.0% | 1,220,413 | +13.2% | 0.01% | +25.0% |
Q4 2013 | $6,304,000 | +20.3% | 1,077,683 | +8.3% | 0.00% | 0.0% |
Q3 2013 | $5,242,000 | -26.0% | 994,639 | +8.1% | 0.00% | -33.3% |
Q2 2013 | $7,084,000 | – | 919,947 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
GAM Holding AG | 523,164 | $997,000 | 0.02% |
STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |